CENPROVA

US serial number:85020829
Application filling date:Apr. 22, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jan. 06, 2014
Publication date:Oct. 05, 2010
Abandoned date:Jan. 06, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith International Class(es): 005- Primary Class U.S Class(es): 006,018,044,046,051,052 Class Status: ACTIVE B
Services:Pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders and complications associated therewith
Current owner owner name:Amgen Inc.
Current owner owner address:One Amgen Center Drive Thousand Oaks, CALIFORNIA UNITED STATES 913201799
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Mark I. Feldman, Christina L. Martini
Attorney email:ch.tm@dlapiper.com
Attorney docket number:211492-73006
Attorney email authorized:Yes
Correspondent name address:MARK I. FELDMAN, CHRISTINA L. MARTINI DLA PIPER LLP (US) PO BOX 64807 CHICAGO, ILLINOIS UNITED STATES 60664-0807
Correspondent phone:312 368 4000
Correspondent email:ch.tm@dlapiper.com
Correspondent fax:312 236 7516
Correspondent email authorized:Yes
Trademark staff tm attorney:LEE, JANET H
Trademark staff law office assigned CENPROVA:LAW OFFICE 102

Reviews

Required fields are marked *